Velocity’s research site in Cleveland was founded in 1997 as Rapid Medical Research Inc. and acquired by Velocity in 2019. Our Cleveland site offers Phase 1-4 multi-therapeutic clinical research experience, including extensive experience with vaccine indications. Other experience includes Women’s Health, Dermatology, Gastroenterology and other Internal Medicine indications. Patient demographics of the site are diverse and range from pediatric to geriatric participants.
Located in Beachwood, OH, just east of metropolitan Cleveland and close to I-271, the site is easily accessible. With more than 6,500 square-feet of dedicated research space, our Cleveland staff can efficiently and effectively conduct multiple concurrent studies. All trials are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. The Velocity Cleveland team is committed to being a resource for study volunteers, to providing the highest quality of patient care with compassion and kindness and to advancing medicine through research.